Search Within

Craig Steven Sauter

Formats
  1. Meeting Abstract (203)
  2. Journal Article (113)
  3. Research Letter (7)
  4. Review (5)
  5. Guidelines (3)
  6. Book Section (2)
  7. Editorial (1)
Groups
  1. Bone Marrow Transplant (334)
  2. Center for Hematologic Malignancies (334)
  3. Department of Medicine (334)
  4. Hematologic Malignancies, Division of (334)
  5. Survivorship Research (233)
  6. CTCR Scholars (204)

More Groups

People
  1. Miguel-Angel Perales (195)
  2. Sergio Giralt (192)
  3. Parastoo Dahi (135)
  4. Sean Devlin (127)
  5. Esperanza Papadopoulos (101)
  6. Juliet Barker (94)

More People

Years
  1. 2024 (1)
  2. 2023 (14)
  3. 2022 (32)
  4. 2021 (36)
  5. 2020 (42)
  6. 2019 (41)

More Years

Publications
  1. Blood (102)
  2. Biology of Blood and Marrow Transplantation (80)
  3. Bone Marrow Transplantation (25)
  4. Transplantation and Cellular Therapy (20)
  5. Blood Advances (18)
  6. Journal of Clinical Oncology (13)

More Publications

Publishers
  1. American Society of Hematology (120)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (34)
  4. American Society of Clinical Oncology (13)
  5. Wiley Blackwell (10)
  6. Taylor & Francis Group (9)

More Publishers

Results (334)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in patients with relapsed/refractory B-cell malignancies
    Meeting Abstract

    Shah, B. D.; Jacobson, C.; Solomon, S. R.; Jain, N.; Johnson, M. C.; Vainorius, M.; Yu, L.; Heery, C. R.; List, A. F.; He, F.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of PBCAR0191, an allogeneic `off-the-shelf' CD19-directed CAR-T for patients with relapsed/refractory (R/R) CD19+ B-ALL
    Meeting Abstract

    Jain, N.; Kantarjian, H.; Solomon, S. R.; He, F.; Sauter, C. S.; Heery, C. R.; List, A. F.; Johnson, M. C.; Lou, Y.; Vainorius, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk peripheral T-cell lymphoma patients treated with CHOP-based chemotherapy
    Meeting Abstract

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Maccaro, C.; Galasso, N.; Sauter, C. S.; Neuman, R.; Khan, N.; Moskowitz, A. J.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Iomab with adoptive cellular therapy (Iomab-ACT): A pilot study of 131-I apamistamab followed by CD19-targeted car T-cell therapy for patients with relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma
    Meeting Abstract

    Geyer, M. B.; Cadzin, B.; Halton, E.; Kane, P.; Senechal, B.; Geoghegan, E. M.; Reddy, V.; Berger, M. S.; Ludwig, D.; Pandit-Taskar, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of choice of platinum-based salvage therapy on CNS relapse in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Buege, M. J.; Dao, P.; Dematteo, R. G.; LeVoir, A.; Pak, T.; Batlevi, C. L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
    Journal Article

    Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Brunstein, C. G.; Cashen, A. F.; Cohen, J. B.; Epperla, N.; Hill, B. T.; Im, A.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
    Guidelines

    Munshi, P. N.; Hamadani, M.; Kumar, A.; Dreger, P.; Friedberg, J. W.; Dreyling, M.; Kahl, B.; Jerkeman, M.; Kharfan-Dabaja, M. A.; Locke, F. L.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of PBCAR0191, an allogeneic, off-the-shelf CD19-targeting CAR-T product, in relapsed/refractory (r/r) CD19+ NHL
    Meeting Abstract

    Shah, B. D.; Jacobson, C. A.; Solomon, S.; Jain, N.; Vainorius, M.; Heery, C. R.; He, F. C.; Reshef, R.; Herrera, A. F.; Akard, L. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save